Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Replimune Group Inc (REPL)

Replimune Group Inc (REPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
View of the trading floor of New York Stock Exchange by Lev Radin via Shutterstock
Signs of Economic Resilience Boost Stocks Barchart - Tue Jun 30, 10:10AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.97%. September E-mini S&P futures...

MSTR : 97.82 (+3.13%)
AMAT : 525.70 (-0.75%)
TW : 100.52 (+0.62%)
SNDK : 1,390.95 (+2.67%)
TTD : 18.64 (+0.27%)
GLXY : 23.66 (+9.39%)
REPL : 10.51 (+2.74%)
CNXC : 24.24 (-0.78%)
TXN : 284.07 (+0.02%)
DLR : 176.25 (+1.36%)
$IUXX : 28,604.23 (+0.04%)
COIN : 160.43 (+2.11%)
Loooking up a tall building in NYC by Andres Garcia via Unsplash
Stock Indexes Supported by Strong Demand for Technology Stocks Barchart - Tue Jun 30, 8:59AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +0.08%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.50%. September E-mini S&P futures...

MSTR : 97.82 (+3.13%)
AMAT : 525.70 (-0.75%)
TW : 100.52 (+0.62%)
SNDK : 1,390.95 (+2.67%)
TTD : 18.64 (+0.27%)
GLXY : 23.66 (+9.39%)
REPL : 10.51 (+2.74%)
CNXC : 24.24 (-0.78%)
TXN : 284.07 (+0.02%)
DLR : 176.25 (+1.36%)
$IUXX : 28,604.23 (+0.04%)
COIN : 160.43 (+2.11%)
Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update GlobeNewswire - Mon Jun 29, 7:00AM CDT

WOBURN, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced...

REPL : 10.51 (+2.74%)
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma GlobeNewswire - Fri Jun 26, 7:00AM CDT

WOBURN, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced...

REPL : 10.51 (+2.74%)
Replimune's Pipeline Data Could Finally Justify the Valuation or Expose the Cash Problem Barchart - Wed Jun 24, 4:01PM CDT

Barchart Research What to Expect from REPL Earnings REPL Generated June 24, 2026 Current Price $11.27 EPS Estimate $$-0.73 Consensus Rating Hold Average Move 3.52% Replimune's Pipeline Data Could Finally...

REPL : 10.51 (+2.74%)
Replimune's Cash Runway Ends Next Quarter Unless the FDA Reverses Course First Barchart - Wed Jun 17, 4:01PM CDT

Barchart Research What to Expect from REPL Earnings REPL Generated June 17, 2026 Current Price $10.00 EPS Estimate $$-0.73 Consensus Rating Hold Average Move 3.52% Replimune's Cash Runway Ends Next Quarter...

REPL : 10.51 (+2.74%)
REPL's Cash Runway Narrative May Finally Collide With Clinical Reality Tomorrow Barchart - Wed Jun 10, 4:01PM CDT

Barchart Research What to Expect from REPL Earnings REPL Generated June 10, 2026 Current Price $8.47 EPS Estimate $$-0.73 Consensus Rating Hold Average Move 3.60% REPL's Cash Runway Narrative May Finally...

REPL : 10.51 (+2.74%)
Replimune's Path to Profitability Grows More Uncertain With Each Delayed Milestone Barchart - Wed Jun 3, 4:02PM CDT

Barchart Research What to Expect from REPL Earnings REPL Generated June 3, 2026 Current Price $9.98 EPS Estimate $$-0.73 Consensus Rating Hold Average Move 3.60% Replimune's Path to Profitability Grows...

REPL : 10.51 (+2.74%)
Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting GlobeNewswire - Sun May 31, 7:00AM CDT

WOBURN, Mass., May 31, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented...

REPL : 10.51 (+2.74%)
Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting GlobeNewswire - Sat May 30, 7:00AM CDT

WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented...

REPL : 10.51 (+2.74%)

Barchart Exclusives

This Dividend King Could Be One of the Safest Stocks to Own Right Now Barchart - Mon Jul 20, 6:30PM CDT
Abbott's diversified healthcare business is one of the main reasons why it remains a reliable dividend stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.